These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3223421)
21. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients. Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566 [TBL] [Abstract][Full Text] [Related]
22. The role of lipid metabolism in dietary treatment of chronic renal failure. Attman PO; Alaupovic P Contrib Nephrol; 1990; 81():35-41. PubMed ID: 2093510 [No Abstract] [Full Text] [Related]
25. Lipoproteins and apolipoproteins during the progression of chronic renal disease. Grützmacher P; März W; Peschke B; Gross W; Schoeppe W Nephron; 1988; 50(2):103-11. PubMed ID: 3221949 [TBL] [Abstract][Full Text] [Related]
26. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Samuelsson O; Mulec H; Knight-Gibson C; Attman PO; Kron B; Larsson R; Weiss L; Wedel H; Alaupovic P Nephrol Dial Transplant; 1997 Sep; 12(9):1908-15. PubMed ID: 9306342 [TBL] [Abstract][Full Text] [Related]
27. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients. Heimann P; Josephson MA; Fellner SK; Thistlethwaite JR; Stuart FP; Dasgupta A Am J Nephrol; 1991; 11(6):470-4. PubMed ID: 1840233 [TBL] [Abstract][Full Text] [Related]
28. Apoprotein A and apoprotein B in patients with chronic renal failure undergoing hemodialysis and in renal graft recipients. Rubiés-Prat J; Romero R; Chacón P; Masdeu S; Griño J; Caralps A Nephron; 1983; 35(3):171-4. PubMed ID: 6355878 [TBL] [Abstract][Full Text] [Related]
29. [Changes in the spectra of lipoproteins and phospholipids in the blood serum of patients with chronic renal failure placed on programmed hemodialysis]. Rozental' RL; Pirogova TF; Zezina LIu Ter Arkh; 1989; 61(6):99-101. PubMed ID: 2799729 [TBL] [Abstract][Full Text] [Related]
30. [Serum lipids in diminished kidney function, during hemodialysis and after kidney transplantation]. Frey FJ; Mordasini RC; Schlumpf E; Marone C; Montandon A; Flury W; Riva G Schweiz Med Wochenschr; 1977 Sep; 107(36):1248-53. PubMed ID: 199937 [TBL] [Abstract][Full Text] [Related]
33. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency. Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104 [TBL] [Abstract][Full Text] [Related]
34. Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure. Attman PO; Gustafson A; Alaupovic P; Wang CS Am J Nephrol; 1984; 4(2):92-8. PubMed ID: 6586074 [TBL] [Abstract][Full Text] [Related]
35. [Abnormal serum VLDL-IDL contents and changes in PHLA (LPH and H-TGL activities) in patients on hemodialysis]. Yukawa S; Morishita S; Miyai T; Maeda T; Takahashi T; Kinoshita M; Miura K; Mune M; Yamada Y; Nomoto H Nihon Jinzo Gakkai Shi; 1983 Jun; 25(6):717-22. PubMed ID: 6663834 [No Abstract] [Full Text] [Related]
36. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)]. Koslík S; Takác M Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304 [No Abstract] [Full Text] [Related]
37. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Attman PO; Alaupovic P Nephron; 1991; 57(4):401-10. PubMed ID: 2046821 [TBL] [Abstract][Full Text] [Related]
38. [Changes in serum lipid levels and the spectrum of individual fatty acids in patients with chronic renal failure on conservative and hemodialysis treatment and their relation to dietary protein intake]. Orbetsova V; Simeonov P; Todorov K; Elazarova F Vutr Boles; 1985; 24(4):63-70. PubMed ID: 4072171 [TBL] [Abstract][Full Text] [Related]
39. Serum lipoprotein (a) levels in patients with chronic renal failure--evolution after renal transplantation and relationship with other parameters of lipoprotein metabolism: a prospective study. Segarra A; Chacón P; Martin M; Vilardell M; Vila J; Cotrina M; Fort J; Olmos A; Piera LL Nephron; 1995; 69(1):9-13. PubMed ID: 7891807 [TBL] [Abstract][Full Text] [Related]
40. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant]. Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]